Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Eikon Therapeutics, Inc. (EIKN : NSDQ)

• Company Description    - Number of Employees: 384

• Price / Volume Information    Yesterday's Closing Price: $9.90 Daily Weekly Monthly 20 Day Moving Average: 410,527 shares Shares Outstanding: 54.14 (millions) Market Capitalization: $535.97 (millions) Beta: 52 Week High: $17.40 52 Week Low: $9.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -31.15% -29.51% 12 Week % % Year To Date % %

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 230 HARRIET TUBMAN WAY - MILLBRAE,CA 94030 USA ph: 341-777-0566 fax: - ir@eikontx.com http://www.eikontx.com

• General Corporate Information    Officers Roger M. Perlmutter - Chief Executive Officer and Chairman Michael Klobuchar - Chief Operating Officer Alfred Bowie - Chief Financial Officer Leon Chen - Director Robert Huffines - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 282564103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: 06/29/26 Share - Related Items Shares Outstanding: 54.14 Most Recent Split Date: (:1) Beta: Market Capitalization: $535.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-1.59 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-6.74 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 06/29/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/26 - - 12/31/25 - - 09/30/25 - - ROA 03/31/26 - - 12/31/25 - - 09/30/25 - - Current Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Quick Ratio 03/31/26 - - 12/31/25 - - 09/30/25 - - Operating Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Pre-Tax Margin 03/31/26 - - 12/31/25 - - 09/30/25 - - Book Value 03/31/26 - - 12/31/25 - - 09/30/25 - - Inventory Turnover 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Equity 03/31/26 - - 12/31/25 - - 09/30/25 - - Debt-to-Capital 03/31/26 - - 12/31/25 - - 09/30/25 - -

Powered by Zacks Investment Research ©